About Oxford Cardiovascular Science

Researchers across Oxford are working together at the forefront of cardiovascular science, with the overall goal of translating discoveries from the laboratory though to clinical practice.  Our researchers will apply new cross cutting technologies to develop cardiovascular imaging and phenotyping, drug development, cardiac computer modelling and stem cell & gene therapy.

We have outstanding experience in conducting clinical trials and epidemiological studies as well as state-of-the-art basic science and clinical reserach facilities. We are particularly proud of our ability to bring together molecular, epidemiological and physiological research to understand cardiac and vascular disease right from the molecular level all the way up to the wider population.

The British Heart Foundation is a key sponsor of cardiovascular research in Oxford and their two research centres offer scientists across the city fantastic opportunities for research & training, supporting the current and next generation of leaders in Cardiovascular Science.

BHF Centre of Research Excellence


The aim of the BHF CRE in Oxford is to emerge as one of the leading cardiovascular centres worldwide. 

The BHF CRE in Oxford brings together over 60 world leading clinical and laboratory researchers, based in Departments and Centres across the University of Oxford. Their research spans diverse areas and covers the translational research spectrum, from basic to clinical research.

BHF Centre of Regenerative Medicine


The ultimate goal of the BHF CRM in Oxford is to understand how the heart might be taught to repair itself after the damage of a heart attack.

The Oxbridge BHF CRM brings together 26 world leading basic and translational research groups (13 based in Oxford, 12 based in Cambridge, and 1 based in Bristol) merging significant expertise in cardiovascular repair and regeneration (Oxford), wound healing (Bristol), with a major focus on stem cells (ESCs and iPSCs) and genetics in the context of regeneration (Cambridge).

News & Events

From bug to drug: tick saliva could be key to treating heart disease

From bug to drug: tick saliva could be key to treating heart disease

Posted 27/06/2017

Proteins found in tick saliva could be used to treat a potentially fatal form of heart disease, according to new Oxford University research. Myocarditis can cause sudden cardiac death in young adults, and occurs when the heart muscle becomes inflamed, often as a result of an infection caused by ...

Prof Hugh Watkins elected Fellow of the Royal Society

Posted 08/05/2017

We’re delighted to announce that the Director of the Oxford BHF Centre of Research Excellence, Prof Hugh Watkins, has been elected a Fellow of the Royal Society. This is a very prestigious honour and one that recognises Hugh’s pioneering heart disease work and commitment to scientific ...

Drugs from bugs

Posted 23/02/2017

LAB282, the £13m drug discovery partnership for Oxford University, has made its first wave of awards, backing projects targeting cardiovascular and infectious diseases. Launched last year as a partnership between the University, Evotec and Oxford Sciences Innovation, LAB282 aids the rapid ...

Congratulations to Dr Charis Antoniades!

Congratulations to Dr Charis Antoniades!

Posted 02/09/2016

  A huge congratulations to Dr Antoniades who has been awarded the Outstanding Achievement award of the European Society of Cardiology. The Award is given each year by the Council of Basic Cardiovascular Science to a basic scientist for their overall contribution to cardiovascular science. This ...

Dr Oliver Rider awarded a BHF Intermediate Clinical Research Fellowship

Posted 02/09/2016

Many congratulations to Dr Oliver Rider, who has been awarded a BHF Intermediate Clinical Research Fellowship (£789K over 4 years), following on from 2 years as an Oxford BHF CRE Transition Research Fellow. Oliver will carry out his research “Comparing the effects of bariatric surgery on the ...

See the news archive